4//SEC Filing
Manning Paul B 4
Accession 0000950170-25-090197
CIK 0001841387other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:30 AM ET
Size
7.2 KB
Accession
0000950170-25-090197
Insider Transaction Report
Form 4
Manning Paul B
Director
Transactions
- Award
Common Stock
2025-06-25$4.67/sh+1,070,663$4,999,996→ 2,213,069 total(indirect: By Trust)
Holdings
- 1,303,752(indirect: By LLC)
Common Stock
- 1,681,000
Common Stock
Footnotes (4)
- [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.
- [F2]The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F3]The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
- [F4]Includes shares held jointly with spouse.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001494695
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 8:30 AM ET
- Size
- 7.2 KB